Evidence map›Paper›PMID 24097429›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2013

The mouse aortocaval fistula recapitulates human arteriovenous fistula maturation.

Kota Yamamoto, Clinton D Protack, Masayuki Tsuneki, Michael R Hall, Daniel J Wong, Daniel Y Lu, Roland Assi, Willis T Williams, Nirvana Sadaghianloo, Hualong Bai and 3 more

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. A Vein Attempt? Experimental Models for Arteriovenous Fistula Research.Cardiovascular engineering and technology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Sustained tenascin-C expression drives neointimal hyperplasia and promotes aortocaval fistula failure.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The rodent models of arteriovenous fistula.Frontiers in cardiovascular medicine · 2024
    Review
  18. American journal of physiology. Renal physiology · 2023
    Article
  19. Sex hormones impact early maturation and immune response in the arteriovenous fistula mouse model.American journal of physiology. Heart and circulatory physiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Kota YamamotoVeterans Affairs Connecticut Healthcare Systems, West Haven, Connecticut;
Clinton D Protack
Masayuki Tsuneki
Michael R Hall
Daniel J Wong
Daniel Y Lu
Roland Assi
Willis T Williams
Nirvana Sadaghianloo
Hualong Bai
Tetsuro Miyata
Joseph A Madri
Alan Dardik
Yale University · USThe University of Tokyo · JPCentre Hospitalier Universitaire de Nice · FRVA Connecticut Healthcare System · US

Funding

ROLES OF HIF-1a IN THE VASCULATURE DURING RECOVERY FOLLOWING CHRONIC SUBLETHAL HYP01NS062686 · NINDS · YALE UNIVERSITY · PI SCHWARTZ, MICHAEL L · 2009 to 2013
$6.6M
Molecular Regulation of Vein Graft AdapationR01HL095498 · NHLBI · YALE UNIVERSITY · PI DARDIK, ALAN · 2009 to 2013
$2.4M
NHLBI NIH HHS R01 HL095498NHLBI NIH HHS R01-HL-095498NINDS NIH HHS P01-NS-062686
6 · The paper itself

Abstract

Several models of arteriovenous fistula (AVF) have excellent patency and help in understanding the mechanisms of venous adaptation to the arterial environment. However, these models fail to exhibit either maturation failure or fail to develop stenoses, both of which are critical modes of AVF failure in human patients. We used high-resolution Doppler ultrasound to serially follow mice with AVFs created by direct 25-gauge needle puncture. By day 21, 75% of AVFs dilate, thicken, and increase flow, i.e., mature, and 25% fail due to immediate thrombosis or maturation failure. Mature AVF thicken due to increased amounts of smooth muscle cells. By day 42, 67% of mature AVFs remain patent, but 33% of AVFs fail due to perianastomotic thickening. These results show that the mouse aortocaval model has an easily detectable maturation phase in the first 21 days followed by a potential failure phase in the subsequent 21 days. This model is the first animal model of AVF to show a course that recapitulates aspects of human AVF maturation.

Indexed as

AnimalsAortaArteriovenous FistulaHumansMiceModels, AnimalUltrasonographyVena Cava, Inferioraortocaval fistulaarteriovenous fistulamaturationmodelmouse

Identifiers

PMID24097429
PMCPMC3882542
OpenAlexW2081857207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.